Current and historical daily PE Ratio for Kaken Pharmaceutical Co Ltd (
TSE:4521
) from 1990 to May 22 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Kaken Pharmaceutical stock (TSE:4521) PE ratio as of May 22 2024 is 44.03.
More Details
Kaken Pharmaceutical Co Ltd (TSE:4521) PE Ratio (TTM) Chart
Kaken Pharmaceutical Co Ltd (TSE:4521) PE Ratio (TTM) Historical Data
View and export this data going back to 1990. Start your Free Trial
Total 1228
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Kaken Pharmaceutical PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-22 | 16.2 | 2024-03-14 | 45.2 |
| 2024-05-21 | 16.2 | 2024-03-13 | 45.1 |
| 2024-05-20 | 16.2 | 2024-03-12 | 45.4 |
| 2024-05-17 | 16.2 | 2024-03-11 | 45.4 |
| 2024-05-16 | 16.2 | 2024-03-08 | 45.1 |
| 2024-05-15 | 15.9 | 2024-03-07 | 45.9 |
| 2024-05-14 | 16.4 | 2024-03-06 | 45.7 |
| 2024-05-13 | 16.7 | 2024-03-05 | 45.5 |
| 2024-05-10 | 16.6 | 2024-03-04 | 45.6 |
| 2024-05-09 | 16.4 | 2024-03-01 | 45.3 |
| 2024-05-08 | 16.4 | 2024-02-29 | 45.5 |
| 2024-05-07 | 16.3 | 2024-02-28 | 45.6 |
| 2024-05-02 | 16.4 | 2024-02-27 | 45.8 |
| 2024-05-01 | 16.4 | 2024-02-26 | 45.5 |
| 2024-04-30 | 16.1 | 2024-02-23 | 45.4 |
| 2024-04-26 | 16.0 | 2024-02-22 | 45.4 |
| 2024-04-25 | 15.9 | 2024-02-21 | 45.4 |
| 2024-04-24 | 16.1 | 2024-02-20 | 45.9 |
| 2024-04-23 | 16.2 | 2024-02-19 | 46.0 |
| 2024-04-22 | 16.3 | 2024-02-16 | 45.3 |
| 2024-04-19 | 16.1 | 2024-02-15 | 44.9 |
| 2024-04-18 | 16.1 | 2024-02-14 | 45.1 |
| 2024-04-17 | 15.9 | 2024-02-13 | 45.4 |
| 2024-04-16 | 16.1 | 2024-02-12 | 44.9 |
| 2024-04-15 | 16.1 | 2024-02-09 | 44.9 |
| 2024-04-12 | 16.2 | 2024-02-08 | 44.8 |
| 2024-04-11 | 16.1 | 2024-02-07 | 45.0 |
| 2024-04-10 | 16.1 | 2024-02-06 | 45.2 |
| 2024-04-09 | 16.1 | 2024-02-05 | 44.9 |
| 2024-04-08 | 16.2 | 2024-02-02 | 44.8 |
| 2024-04-05 | 16.2 | 2024-02-01 | 44.9 |
| 2024-04-04 | 16.1 | 2024-01-31 | 44.7 |
| 2024-04-03 | 16.1 | 2024-01-30 | 44.7 |
| 2024-04-02 | 16.1 | 2024-01-29 | 44.7 |
| 2024-04-01 | 16.3 | 2024-01-26 | 44.7 |
| 2024-03-29 | 16.3 | 2024-01-25 | 44.8 |
| 2024-03-28 | 16.1 | 2024-01-24 | 44.6 |
| 2024-03-27 | 46.0 | 2024-01-23 | 44.8 |
| 2024-03-26 | 46.1 | 2024-01-22 | 44.7 |
| 2024-03-25 | 46.0 | 2024-01-19 | 44.3 |
| 2024-03-22 | 46.2 | 2024-01-18 | 44.7 |
| 2024-03-21 | 45.6 | 2024-01-17 | 44.8 |
| 2024-03-19 | 45.5 | 2024-01-16 | 44.9 |
| 2024-03-18 | 45.4 | 2024-01-15 | 44.6 |
| 2024-03-15 | 45.1 | 2024-01-12 | 44.6 |
Kaken Pharmaceutical Co Ltd (TSE:4521) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Kaken Pharmaceutical Co Ltd
NAICS : 325411
SIC : 2833
ISIN : JP3207000005
Share Class Description:
TSE:4521: Ordinary SharesDescription
Kaken Pharmaceutical Co is a specialty and generic drug manufacturing company. The company organizes its segments between pharmaceutical and real estate activities. The pharmaceutical segment consists of pharmaceutical drugs, medical devices, and agrochemicals. In the real estate segment, the majority of revenue is generated through commercial facility rental fees. Sales in Japan constitute more than 90% of revenue. Kaken considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers